Nutra Labs Inc. Issues Voluntary Nationwide Recall of Dietary Supplements Bull and Chao Jimengnan Tablets Due to Undeclared Active Pharmaceutical Ingredients
Nutra Labs Inc. is voluntarily recalling lots sold by their firm of the male enhancement supplements Bull 1800 mg Capsules with the production date of 05/08/2016, and Chao Jimengnan 150 mg Tablets with Lot # 20151018 to the consumer level. FDA analysis found the products to be tainted with sildenafil, 0.026mg/capsule for Bull, and 70.46mg/tablet for Chao Jimengnan respectively. Sildenafil is the active pharmaceutical ingredient in an FDA approved product used for erectile dysfunction, making Bull capsules and Chao Jimengnan tablets unapproved new drugs.
Tramadol dependence is a public health problem in Egypt. We aimed to determine the sociodemographic and clinical characteristics of tramadol abuse among Egyptians, the frequency and degrees of insomnia among tramadol abusers, and the relationship between the associated insomnia with sociodemographic and clinical characteristics. Included in this study were 400 subjects (mean age, 30.72±9.61 y) who were tramadol dependent. The subjects were assessed using Structured Clinical Interviewing using DSM-IV (SCID-I), Severity of Dependence Scale (SDS), and Insomnia Severity Index. We found that the mean age at onset ...
AbstractPurpose of ReviewErectile dysfunction (ED) is a burden for the majority of men during their lifetime. Phosphodiesterase type-5 inhibitors are first-line treatment for men with ED; however, they are limited by on-demand dosing, short-term benefits, and reduced efficacy in difficult to treat populations such as men with diabetes mellitus or ED after radical prostatectomy.Recent FindingsNovel treatment options that offer a durable, tissue restorative approaches are being explored and potentially offer a long-term solution to this medical affliction. Medical therapies such as nanoparticles and botulinum neurotoxin, new...
AbstractPurpose of ReviewIn this article, we review the most recent articles examining the use of testosterone for the treatment of erectile dysfunction, reduced sexual desire, and ejaculatory dysfunction.Recent FindingsThe treatment of erectile dysfunction with testosterone therapy has long been investigated as a cure for sexual dysfunction. Men who are testosterone deficient can expect to benefit from testosterone therapy to address erectile dysfunction and libido, while ejaculatory function is unlikely to improve.SummaryThe literature supports the use of testosterone therapy in testosterone-deficient men with sexual dys...
The relationship between penile deformity, age, psychological bother, and erectile dysfunction in a sample of men with Peyronie’s Disease (PD)The relationship between penile deformity, age, psychological bother, and erectile dysfunction in a sample of men with Peyronie’s Disease (PD), Published online: 25 May 2018; doi:10.1038/s41443-018-0029-3The relationship between penile deformity, age, psychological bother, and erectile dysfunction in a sample of men with Peyronie’s Disease (PD)
Association between obstructive sleep apnea and erectile dysfunction: a systematic review and meta-analysis, Published online: 25 May 2018; doi:10.1038/s41443-018-0017-7Association between obstructive sleep apnea and erectile dysfunction: a systematic review and meta-analysis
Conclusions Overall, receipt of genitourinary prosthetic surgery for incontinence (1.5%) or erectile dysfunction (1.6%) was rare following radical prostatectomy. However, diabetic and older men demonstrated a greater likelihood of device placement.
Relation between hypertension and erectile dysfunction: a meta-analysisof cross-section studies, Published online: 22 May 2018; doi:10.1038/s41443-018-0020-zRelation between hypertension and erectile dysfunction: a meta-analysisof cross-section studies
An initial study on the effect of functional electrical stimulation in erectile dysfunction: a randomized controlled trial, Published online: 22 May 2018; doi:10.1038/s41443-018-0024-8An initial study on the effect of functional electrical stimulation in erectile dysfunction: a randomized controlled trial
Conclusion Exendin-4 treatment improves NO-mediated CC relaxations in MGO administered rats probably by inhibiting NADPH oxidase.
The team at the University of Ottawa found that erectile dysfunction drugs block suppressor cells, allowing natural killer cells to do their cancer-fighting job. The flu vaccine further invigorates the killer cells.